Caricamento...
Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
PURPOSE: To evaluate the use of docetaxel in very elderly men with metastatic castration-resistant prostate cancer (mCRPC) treated in routine clinical care. METHODS: A retrospective case series of men with mCRPC aged ≥80 years and treated with docetaxel between July 2006 and June 2012 at three commu...
Salvato in:
| Pubblicato in: | Prostate Int |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Asian Pacific Prostate Society
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494632/ https://ncbi.nlm.nih.gov/pubmed/26157766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2015.03.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|